Louisiana 2022 Regular Session

Louisiana Senate Bill SB378

Introduced
3/4/22  
Introduced
3/4/22  
Refer
3/4/22  
Refer
3/14/22  
Refer
3/14/22  
Report Pass
4/27/22  
Report Pass
4/27/22  
Engrossed
5/5/22  
Engrossed
5/5/22  
Refer
5/9/22  
Refer
5/9/22  
Report Pass
5/23/22  
Enrolled
6/6/22  
Chaptered
6/18/22  
Chaptered
6/18/22  

Caption

Provides for the regulation of advertisements. (8/1/22)

Impact

The bill has the potential to significantly impact state laws concerning advertising practices, particularly for sectors related to healthcare and medical products. By implementing strict criteria for what constitutes a deceptive advertisement, it aligns with efforts to protect consumers from misleading marketing tactics. This move aims to foster a fairer advertising environment, especially for vulnerable populations who may be misled by aggressive marketing strategies in the medical field.

Summary

Senate Bill 378 introduces regulations pertaining to advertisements in Louisiana, specifically targeting unfair or deceptive acts in advertising practices. The bill establishes clear definitions and parameters for advertisements related to medical devices and prescription drugs. It prohibits advertisements from being misleadingly presented as medical alerts or using government agency logos to imply federal or state endorsement. Specific requirements for disclosures within advertisements are mandated to enhance transparency for consumers.

Sentiment

Overall, the sentiment surrounding SB378 appears positive, with widespread support from legislators focused on enhancing consumer protections. However, concerns were raised by some stakeholders regarding the feasibility of enforcing the regulations and the implications for advertising freedom. Supporters emphasize the necessity of providing clear and truthful information in advertisements to improve public health outcomes, while opponents express caution about the potential restrictions on legitimate advertising practices.

Contention

One notable point of contention relates to how the bill distinguishes between genuine medical advice and deceptive advertisements. Critics argue that while the intention of the bill is commendable, it could inadvertently restrict essential information dissemination in a market needing guidance. Furthermore, debates ensued about the burdens that such regulations could place on small businesses and their advertising capabilities, leading to discussions on balancing consumer protection with business interests.

Companion Bills

No companion bills found.

Previously Filed As

LA SB43

Provides for the regulation of certain advertisements for legal services. (8/1/21)

LA SB346

Provides for the regulation of legal advertising in the field of medical alerts. (8/1/20)

LA H1205

Advertisements for Legal Services

LA SB383

Provides relative to advertisements for legal services. (gov sig)

LA HB445

Provides relative to attorney advertising

LA SB305

Provides for the disclosure of certain information on websites and online services. (8/1/22)

LA SB290

Provides relative to the regulation of sports wagering. (7/1/22)

LA SB1189

Relating to certain deceptive advertising of legal services.

LA SB1505

Establishes provisions relating to the unlawful merchandising practices in the advertising of legal services

LA SB122

Prohibits certain forms of untrue or misleading advertisements. (8/1/16)

Similar Bills

CA AB2899

Cannabis: advertisements.

VA HB489

Campaign advertisements; independent expenditures, electioneering communications, etc.

VA SB318

Campaign advertisements; independent expenditures, electioneering communications, disclaimer.

CA AB1302

Commercial cannabis billboards: placement restrictions.

CA AB273

Cannabis: advertisements: highways.

VA SB906

Campaign advertisements; independent expenditures, electioneering communications.

VA HB1551

Campaign advertisements; independent expenditures, electioneering communications, disclaimer.

VA SB854

Campaign advertisements; independent expenditures, electioneering communications.